# Checklist to Prevent MRSA Surgical Site Infections

> **NCT02216227** · NA · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 23005 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** Mupirocin
- **DRUG:** Chlorhexidine gluconate
- **DRUG:** Cefazolin
- **DRUG:** Vancomycin
- **DRUG:** Nasal Povidone Iodine

## Key facts

- **NCT ID:** NCT02216227
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-01
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 23005 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216227, "Checklist to Prevent MRSA Surgical Site Infections". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02216227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*